Track record · closed signal

Morgan Stanley (MS) — closed signal from October 20, 2025

Target reached Published before the outcome was known, scored automatically when the window closed on January 18, 2026 — +17.7% at the close.

Predicted vs. what happened

MS price · publication thesis → realized outcomesplit-adjusted

$156.59 – $161.03Entry zone — fair-value band

$160.59Published — price the day we called it

$185.15Target — the price the thesis aimed for

$192.68Peak — highest point inside the window, not a realized return

$189.09Window close — end-of-window price, context only

What happened

Target reached

Reached its target in 77 days.

At window close

+17.7%

realized, from the publication price to the last close inside the window

Peak gain

+20%

peak, from the publication price — not a realized return

S&P 500, same window

+3.3%

SPY over the identical days, dividend-adjusted

Window close

$189.09

last close inside the window, ended January 18, 2026

Peak price

$192.68

peak on January 16, 2026 — not a realized return

Days to target

The thesis — published October 20, 2025

Predicted growth

+16%

over the measurement window

Target price

$185.15

the price the thesis aimed for

Entry zone

$156.59 – $161.03

the fair-value band we waited for

Price at publication

$160.59

published October 20, 2025

Confidence

69%

how strongly the data lined up

Timeframe

Short-term (0–3 months)

Morgan Stanley could benefit as company profits across the market are expected to rise about 8.5% in Q3, which supports steady wealth management and banking activity. Investor mood is upbeat, and the price trend looks healthier, with the recent average price improving. For the next 1-3 months, a gradual climb is likely as more investors take risk, lots more people are buying than usual, and trading interest returns.

Primary drivers

Stronger profit outlook supports steady wealth and banking activity in the near term
Upbeat mood and healthier price trend, with recent average price improving
Large, stable wealth business offers dependable fees and cross-selling
Buying in stages matches a patient plan for a steady climb over weeks

How it played out

MS: target reached in 77 days

On 2025-10-20, Lyra published a short-term MS thesis at $160.59. It expected 16% growth toward $185.15. The thesis pointed to a stronger profit outlook, steady wealth and banking activity, upbeat investor mood, a healthier price trend, a large wealth business, and buying in stages for a patient climb over weeks.

Inside the window, MS reached the target. The peak was $192.68 on 2026-01-16, with a 20% gain, and the target was reached in 77 days. The window ended at $189.09. The published thesis played out.

What happened during the window

On 2025-10-29, Morgan Stanley agreed to buy EquityZen, a platform for trading shares of private companies. On 2026-01-15, Financial News reported Morgan Stanley's fourth-quarter investment banking net revenue rose 47% to $2.4 billion.

Prices are shown split- and dividend-adjusted, matching what public charts show today.

Lyra

Read the next call before it closes.

This is one signal, scored after the fact. Today’s picks come with the same plain-language thesis — published before anyone knows the outcome.

See today’s picks All MS signals